Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

NCT05047055 · clinicaltrials.gov ↗

UNKNOWN

Status

550

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

DRUG: Isoniazid
DRUG: Rifampicin
DRUG: Pyrazinamide
DRUG: Ethambutol
DRUG: Moxifloxacin

Sponsor

Tuberculosis Research Centre, India

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]